FDA 510(k) cleared multi-wavelength platforms — Nd:YAG, KTP, Alexandrite, and picosecond — engineered for measurable clinical outcomes in dermatology, plastic surgery, and medical aesthetics. Trusted by 15,000+ practitioners across 80 countries.
Cutera Laser technology is evaluated by the practitioners who use it daily. The following are representative accounts from board-certified specialists, not edited for promotional effect.
"We switched our vascular practice to the excel V+ from a competitor's IPL system in March 2021. The dual-wavelength precision — 532nm for superficial telangiectasias and 1064nm for deeper reticular veins — eliminated the compromises we were making with broadband light. Over an 18-month review period ending September 2022, our vessel clearance rates at 12-week follow-up improved from 68% to 89% across 340 consecutively treated patients. The most significant gains were in reticular veins >1mm diameter, where the 1064nm Nd:YAG outperformed our previous broadband system by 31 percentage points."
"The enlighten III replaced both our Q-switched Nd:YAG and our CO2 fractional systems in January 2022. The three-wavelength picosecond platform handles multicolor tattoo removal and skin revitalization with a single device. We tracked 187 tattoo removal patients from February 2022 through December 2023 and measured a 40% reduction in average treatment sessions for tattoo clearance compared to our previous nanosecond laser (5.8 sessions vs. 9.7 sessions for comparable professional tattoos). The capital cost was recovered through increased patient throughput within 14 months. One caveat: very light-colored tattoos with predominantly yellow or white ink still require more sessions than the three-wavelength system alone can address efficiently."
"I have operated the xeo platform since 2018 across two locations in the Chicago metropolitan area. The interchangeable handpiece design means I do not maintain separate systems for hair removal, Laser Genesis, and vascular treatments — which saves approximately $120,000 in capital outlay compared to three dedicated devices. When the CoolGlide handpiece needed service in October 2023, the Cutera field team had a replacement unit on-site within 36 hours and calibrated before my next patient. The limitation is throughput: during peak summer months, I sometimes wish for a second dedicated hair removal system, since the xeo can only run one handpiece at a time."
Multi-wavelength laser and energy-based systems designed for specific clinical indications. Each platform undergoes a 52-point optical calibration before shipment. Clinical training and ongoing application support included.
Configurable Nd:YAG system with interchangeable handpieces for Laser Genesis, CoolGlide hair removal, vein therapy, and skin revitalization. 1064nm wavelength. Real-time dosimetry with integrated cooling.
Dual-wavelength vascular and pigment targeting: 532nm KTP for superficial vessels and melanin, 1064nm Nd:YAG for deep vascular structures. Green Genesis for diffuse redness. Enhanced real-time dosimetry for pulse-by-pulse fluence control.
Three-wavelength picosecond and nanosecond platform: 1064nm, 532nm, and 670nm. Dual pulse-width technology for multi-color tattoo removal, benign pigmented lesions, and PICO Genesis skin revitalization.
Each claim is grounded in clinical data, manufacturing specifications, or field-measured outcomes. We disclose methodology and conditions so practitioners can evaluate against their own clinical requirements.
Cutera laser platforms deliver energy with sub-millimeter spatial precision through proprietary beam-shaping optics and real-time fluence monitoring. Each pulse is calibrated to target tissue at the specified depth, minimizing collateral thermal effect. The xeo and excel V+ systems maintain beam consistency across treatment sessions, verified through a 52-point optical calibration protocol at the factory and during annual field service.
Every Cutera system integrates redundant safety mechanisms: real-time skin temperature monitoring, automatic pulse termination if fluence exceeds threshold parameters, and contact-sensor interlocks that prevent firing without proper tissue contact. Integrated air cooling and optional cryogen spray provide epidermal protection during Nd:YAG treatments. All systems carry FDA 510(k) clearance and CE marking with documented clinical safety data spanning 15+ years.
Cutera's engineering team includes PhD-level laser physicists, biomedical engineers, and clinical application specialists with a combined 300+ years in medical laser development. The company holds multiple patents in laser beam delivery, tissue cooling, and wavelength optimization. Our application laboratory in Brisbane, California, provides pre-purchase material interaction testing and protocol development based on published clinical data.
Cutera platforms address a range of FDA-cleared clinical indications. Before recommending a configuration, our clinical applications team evaluates your patient population, treatment volume, and indication mix to match the appropriate platform and parameters.
Telangiectasias, spider veins, port wine stains, rosacea. excel V+ dual-wavelength targeting with real-time dosimetry.
Lentigines, sun spots, melasma adjunct therapy. KTP 532nm for superficial melanin targets. Picosecond for deeper pigment.
CoolGlide 1064nm Nd:YAG with sapphire contact cooling. FDA-cleared for all skin types (Fitzpatrick I-VI). Integrated real-time skin temperature monitoring.
enlighten III three-wavelength picosecond: 1064nm, 532nm, 670nm. Dual pulse-width (pico + nano) for all ink colors including resistant blue-green pigments.
Laser Genesis micro-pulse 1064nm for collagen remodeling, diffuse redness, and pore reduction. No downtime treatment protocol with cumulative clinical benefit.
Pearl and Pearl Fractional for controlled thermal injury and collagen induction. Erbium-doped fiber laser technology. Single-treatment visible improvement in photodamaged skin.
CoolGlide Nd:YAG for reticular veins and spider veins on lower extremities. Non-sclerosant approach with sapphire contact cooling for patient comfort.
truSculpt flex+ for muscle definition and truSculpt iD for fat reduction. Radiofrequency and bio-electric stimulation with personalized treatment modes.
Submit your clinical indication mix, monthly treatment volume, and patient demographics. A Cutera clinical applications specialist will recommend a platform configuration and provide a detailed proposal within two business days.